You are here
Depressant fluvoxamine not effective in reducing COVID inflammation--study
Primary tabs
Depressant fluvoxamine not effective in reducing COVID inflammation--study
Tue, 2023-09-19 19:43 — mike kraft Study shows no benefits of antidepressant for COVID-19 symptoms - UPI.com Researchers studied fluvoxamine because previous evidence suggested that it might be able to reduce inflammation caused by the virus. UPI
A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments